Stock comparison
Medpace Holdings, Inc. is 1.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($15.29 B vs $11.25 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MEDP is larger
Medpace Holdings, Inc. is 1.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($15.29 B vs $11.25 B).
Market value leader
MEDP
Medpace Holdings, Inc. is 1.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($15.29 B vs $11.25 B).
Revenue leader
CRL
MEDP: $2.53B vs CRL: $4.02B.
Profit leader
MEDP
MEDP: $451.12M vs CRL: -$144.34M.
Margin leader
MEDP
MEDP: 17.8% vs CRL: -3.6% net margin.
| Metric | MEDP | CRL |
|---|---|---|
| Market cap | $15.29 B | $11.25 B |
| US-listed rank | #731 | #889 |
| Revenue (latest FY) | $2.53B | $4.02B |
| Net income (latest FY) | $451.12M | -$144.34M |
| Net margin | 17.8% | -3.6% |
| P/E (trailing FY) | 33.9x | - |
| SEC filings | 874 | 2,387 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medpace Holdings, Inc. is 1.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($15.29 B vs $11.25 B).
In their latest fiscal years, Medpace Holdings, Inc. reported $2.53B in revenue while CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported $4.02B.
Full pages: Medpace Holdings, Inc. and CHARLES RIVER LABORATORIES INTERNATIONAL, INC., or browse the full rankings.